![]() Press Release Distribution |
vaccine Latest News+ XML/RSSBy Fast Market Research Recently published research from Datamonitor, "Sanofi-Aventis: PharmaVitae Profile", is now available at Fast Market Research By WoahMedia.com New evidence suggests vaccinated children and adults suffer from significantly more ADHD, neurologic disorders, autism, asthma, allergies, respiratory infections and many other potentially serious illnesses, including cancer. By Cambridge Healthtech Institute Today, Inovio Pharmaceuticals reports long-term immune responses from therapeutic cervical dysplasia and cancer DNA vaccine. Mark Bagarazzi, M.D., Chief Medical Officer, will speak at CHI's Clinical Development of Vaccines conference. By Cambridge Healthtech Institute Vaccine leaders to convene at four co-located conferences on August 16-18, 2011 in Cambridge, Mass. By Fast Market Research New Healthcare research report from Business Monitor International is now available from Fast Market Research By Fast Market Research Recently published research from Business Monitor International, "Saudi Arabia Pharmaceuticals & Healthcare Report Q2 2011", is now available at Fast Market Research By Organization of Teratology Information Specialists OTIS Joins The Effort To Raise Awareness Of Meningitis Prevention By Fast Market Research Fast Market Research recommends "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available By Fast Market Research New Pharmaceuticals research report from GlobalData is now available from Fast Market Research By Fast Market Research New Healthcare market report from GlobalData: "Hester Biosciences Limited (524669) - Financial and Strategic Analysis Review" By Fast Market Research New Pharmaceuticals research report from GlobalData is now available from Fast Market Research By Fast Market Research New Pharmaceuticals market report from Datamonitor: "Pipeline and Commercial Insight: Pneumococcal and Meningococcal Vaccines" By Fast Market Research New Healthcare research report from Business Monitor International is now available from Fast Market Research By Jonathan Joel Regulatory Officials recently made huge advances in Artificial Immune Function Technology Transitions for Assessing Vaccine and Biothreats Efficacy; whereby Knight Officials considered the legislative impact. By Fast Market Research New Pharmaceuticals market report from GlobalData: "Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2017" By Danny Aronovic BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company developing a Universal Influenza Vaccine, today announced that it has raised $1.25 million under its Standby Equity Distribution Agreement (SEDA) with YA Global Investments L.P. By Danny Aronovic Dr. Tamar Ben-Yedidia will be presenting at the Influenza Congress USA next week in Washington, D.C. BiondVax is currently in Phase IIa clinical trials (human subjects) for its Universal Influenza Vaccine. By Miles for Hope Miles For Hope, a Clearwater charity, will be the recipient of proceeds from a fundraising challenge set to raise critically needed awareness and funding of brain tumors By Kalorama Information Breast cancer accounts for approximately 12% of all cancers worldwide. In the U.S. more than 200,000 people develop breast cancer each year, with more than 95% of these women. By Bharatbook Bharatbook added a new report on "Global Vaccine Market Forecast to 2012" which gives extensive research and objective analysis of the vaccine market in key countries of the world. By RNCOS. By Danny Aronovic Dr. Tamar Ben-Yedidia will be speaking at the upcoming World Vaccine Congress in Lyon, France on October 4, 2010. She will be updating the congress on the company's progress and upcoming Phase II trials starting in October. By ResearchInChina ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report - China Vaccine Industry Report, 2009-2010. For more information, please contact us at report@researchinchina.com or at 86-10-82600828. By Pirages Communications for Jewel-Osco To meet the demand for this year's flu season, specially trained and certified JEWEL-OSCO pharmacists are available to administer the flu vaccine at nearly all JEWEL-OSCO pharmacies. By Kalorama Information Drug delivery has become an important focus of the industry. Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. By Mark Warne The FDA is to assess the feasibility of Glythera technology in developing antigenic glycoproteins as synthetic conjugate vaccines. By Miles for Hope Miles for Hope, a Clearwater charity, will be the recipient of proceeds from a charity pool tournament to raise brain tumor awareness and funding for a brain tumor vaccine clinical trial By Pirages Communications for Jewel-Osco Every year, at least 1 million people in the United States develop the painful skin rash shingles. JEWEL-OSCO is offering shingles vaccinations at all of its in-store pharmacies. BiondVax Announces Approvals for Initiation of First Phase II Trials for Universal Influenza Vaccine By Danny Aronovic BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine By Miles for Hope Miles for Hope seeks to raise $ 250,000 to open the first clinical trial for custom life-saving cancer vaccine for pediatric patients and adults with low-grade brain cancer By Danny Aronovic According to Frost & Sullivan, BiondVax is the leading company in the quest for the universal influenza vaccine and has received Frost & Sullivan’s 2010 European Influenza Vaccines Technology Innovation Award. By Fast Market Research New Healthcare research report from Datamonitor is now available from Fast Market Research By Aarkstore Enterprise Aarkstore announce a new report "H1N1 "Swine Flu" Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)" through its vast collection of market reserach report. By Imapac Pte Ltd BioManufacturing World and Vaccine manufacturing World Events are co-located events that will be held in Shanghai, China in Oct 2010. By 168REPORT 2010 Report on China Animal Vaccine Industry By Dan Aronovic Chief Scientific Officer, Dr. Tamar Ben Yedidia, will provide an overview of the Company's technology and clinical development progress at two upcoming biopharma industry conferences in Israel and Barcelona, Spain By Fast Market Research New Healthcare market report from Business Monitor International: "Bangladesh Pharmaceuticals & Healthcare Report Q3 2010" By Fast Market Research Fast Market Research recommends "Netherlands Pharmaceuticals & Healthcare Report Q3 2010" from Business Monitor International, now available By CCM International Limited Biopharmaceuticals China News is a monthly report with 12 issues per annum published by CCM International Limited. It's your gateway to know latest news like Investment Focus, Governmental Policies,Market Dynamics,and Technology & New Products,etc. By Bharatbook Bharatbook added a new report on "H1N1 Swine Flu Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)" into its market report catalogue for reselling. By Fast Market Research Recently published research from GlobalData, "Tuberculosis - Drug Pipeline Analysis and Market Forecasts to 2016", is now available at Fast Market Research By Fast Market Research New Pharmaceuticals research report from Business Insights is now available from Fast Market Research By PRStreet, Inc. Club to Raise Polio Awareness in Downtown Apex By Mark Vander Hoff Noesys Data has been selected by The Transformational Medical Technologies Initiative (TMTI) Program Office to present a capability brief to TMTI Performers at the upcoming TMTI Partnership Symposium May 3-4 2010. By Charak Clinics Yellow Fever Vaccine Available for North India, Punjab, Chandigarh, Haryana, Himachal, J & K, UP at By Fast Market Research Fast Market Research recommends "Japan Pharmaceuticals & Healthcare Report Q2 2010" from Business Monitor International, now available By Dan Aronovic BiondVax Reports Positive Interim Safety Results from Second Phase I/II Universal Influenza Vaccine Trial BiondVax’s Multimeric-001 Universal Flu Vaccine Shown to be Safe and Well Tolerated in trial of 60 elderly participants By Fast Market Research Recently published research from Business Monitor International, "Uzbekistan Pharmaceuticals & Healthcare Report Q2 2010", is now available at Fast Market Research By Fast Market Research New Healthcare market report from Business Monitor International: "Bangladesh Pharmaceuticals & Healthcare Report Q2 2010" By Tom Bionic Surgeon and radio show host stan monteith exposes the deadly and hidden legacy of our immunization and public health policies, on the 22 - 26 feb 10 “future quake” radio programs By daisywright As the death ratio of females due to cervical cancer was getting above from par, experts and researchers came up with the solution in the form of a vaccination that can contribute in reducing the ratio to the least. Over a period of time. |
|